Navigation Links
Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results
Date:7/17/2008

p>Receivables 2,217 2,026

Inventories 2,571 2,334

Other current assets 624 656

------------------------------------

Total current assets 7,559 7,555

------------------------------------

Property, plant and equipment, net 4,680 4,487

Other long-term assets 3,231 3,252

--------------------------------------------------------------------------

Total assets $15,470 $15,294

==========================================================================

Liabilities and Shareholders' Equity

------------------------------------

Short-term debt $62 $425

Other current liabilities 3,331 3,387

Long-term debt 3,172 2,664

Other long-term liabilities 1,686 1,902

Shareholders' equity 7,219 6,916

--------------------------------------------------------------------------

Total liabilities and

shareholders' equity $15,470 $15,294

==========================================================================

BAXTER INTERNATIONAL INC.

Cash Flows from Operations and Changes in Net Debt

(unaudited)

($ in millions)

Cash Flows from Operations

(Brackets denote cash outflows) Three Months Ended Six Months Ended

<
'/>"/>
SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
2. Baxters Board of Directors Declares Quarterly Dividend
3. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
4. Baxters V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
5. Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
6. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
7. Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally
8. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
9. Baxter Declares Quarterly Dividend
10. Baxter Provides Update on Heparin Reactions
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 Proove Biosciences , ... excited to announce a new genetic test built upon ... Pain Perception Test will provide physicians with an ... pain tolerance levels are stratified between individuals. With this ... a person has a genetic predisposition that will affect ...
(Date:9/30/2014)... , Sept. 30, 2014  RegeneRx Biopharmaceuticals, ... announced that it has received a Canadian Patent ... Actin-Sequestering Peptides.  This patent includes claims using thymosin ... other actin-sequestering peptides for these purposes.  The patent ... RegeneRx Biopharmaceuticals, Inc. ( www.regenerx.com ) ...
(Date:9/30/2014)... Fast, semi-automatic creation of ... documents ChemAxon , a leader ... for life science research, launches ChemCurator, an application ... from documents. Markush structures are essential ... and understanding Markush structures is a difficult and ...
(Date:9/30/2014)... CA (PRWEB) September 30, 2014 OriginOil ... the high-speed, chemical-free process to clean up large quantities ... shareholders, CEO Riggs Eckelberry reported on the launch of ... at a site provided by partner STW Resources ... to 1000 barrels per day (bpd) and achieved a ...
Breaking Biology Technology:Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2
(Date:9/29/2014)... order to support the world,s needs to make ... more, new and more efficient catalytic materials and ... including several from Wayne State University, is tackling ... grant from the National Science Foundation. , The ... Multicomponent Materials for Electrocatalytic Cascade Reactions," was to ...
(Date:9/29/2014)... Scientists at Washington State University have concluded ... Smith apples may help prevent disorders associated ... first to assess these compounds in apple cultivars ... print edition of the journal Food Chemistry ... a good source of these nondigestible compounds but ...
(Date:9/29/2014)... presented Dr. Cristin Samper, president and CEO of ... of San Carlos. , The Order of San ... officers who have made outstanding contributions to the ... , An international authority on conservation biology and ... Colombian Residence in New York to receive the ...
Breaking Biology News(10 mins):Wayne State research aims to develop new, more efficient catalytic materials 2An apple a day could keep obesity away 2
... leukemia reversed symptoms of colitis in lab tests, according to ... Alberta. Faculty of Medicine & Dentistry researcher Shairaz Baksh ... ONE . His team discovered that a ... development of colitis. When this gene quits working or is ...
... medicines, enzymes for the food, cosmetics, and detergent industries: ... large scale using biotechnology. Currently, demand for biomolecules is ... or organisms. This involves researchers adding the gene that ... cultures of animal or plant cells. These modified organisms ...
... hosting a conference for researchers and clinicians on depression, ... Treatment Battlefeld and New Research," on Friday, November 1, ... Icahn School of Medicine at Mount Sinai, The Bonnie ... and 102nd Streets) in New York City. Recent meta-analyses ...
Cached Biology News:UAlberta medical researchers discover potential new treatment for colitis 2UAlberta medical researchers discover potential new treatment for colitis 3Biomolecules for the production line 2Biomolecules for the production line 3Towards a real understanding of depression 2